A measles epidemic can be anticipated when the proportion of susceptible children in a community reaches what level?
An investigator found an association between beta carotene consumption and reduced risk of colon cancer. However, it was later found that this association might be due to increased fiber intake in such diets. What is this type of occurrence termed?
Which strain of influenza was declared as a pandemic?
Which of the following is characteristic of a single exposure common vehicle outbreak?
Breteau Index is used for the identification of breeding sites of which mosquito?
In which of the following cancers is screening least useful?
Which of the following stages of the demographic cycle is characterized by a declining population?
What is the most common cancer worldwide?
A new drug with in vitro activity against HIV is tested on a population of patients with Western-blot confirmed HIV infections in Mumbai. Out of the 200 individuals in the patient population, 100 individuals are chosen randomly to receive the drug. The drug, which is tasteless, is administered in a cup of orange juice; the other patients receive pure orange juice. Neither the nurses, doctors, nor patients know which patients receive the drug. At the end of the study period, the number of CD4+ T cells is determined for all of the subjects. What is the research method used in this study?
The extent to which a specific health care treatment, service, procedure, program or other intervention does what it is intended to do when used in a community dwelling population is termed its:
Explanation: **Explanation:** The correct answer is **40%**. This question is based on the concept of **Herd Immunity** and the **Critical Vaccination Threshold**. Measles is one of the most highly infectious diseases known, with a Basic Reproduction Number ($R_0$) typically ranging from 12 to 18. To prevent an epidemic, a very high level of herd immunity (approximately 94–95%) is required. In epidemiological terms, a measles outbreak is anticipated when the proportion of susceptible individuals in a population reaches a "critical mass." According to standard public health guidelines and historical epidemiological data (often cited in Park’s Textbook of Preventive and Social Medicine), an epidemic is likely to occur when the proportion of susceptible children reaches **40%**. **Analysis of Options:** * **A (20%):** At this level, the herd immunity is 80%. While outbreaks can occur, the population is generally more stable than at the 40% threshold. * **B (40%):** This is the established threshold where the density of susceptible hosts is high enough to sustain rapid transmission, leading to an epidemic. * **C & D (60% & 80%):** At these levels, the population is highly vulnerable. An epidemic would have likely already started or peaked long before reaching these proportions of susceptibility. **High-Yield Clinical Pearls for NEET-PG:** * **Herd Immunity Threshold formula:** $1 - (1/R_0)$. For Measles, with an $R_0$ of 15, the threshold is $1 - (1/15) \approx 93.3\%$. * **Secondary Attack Rate (SAR):** Measles has a SAR of $>90\%$ among susceptible household contacts. * **Eradication vs. Elimination:** Measles is a candidate for elimination, but not yet eradicated globally. * **Vaccine:** The Measles vaccine is a live attenuated vaccine (Edmonston-Zagreb strain in India), administered at 9 months and 16–24 months.
Explanation: ### Explanation **1. Why "Confounding Factor" is Correct:** A **confounder** is an extraneous variable that is associated with both the exposure (beta carotene) and the outcome (colon cancer), and is not an intermediate step in the causal pathway. In this scenario, individuals who consume high amounts of beta carotene often consume a diet high in vegetables, which are also rich in **fiber**. Since fiber is independently known to reduce colon cancer risk, the apparent protective effect of beta carotene is actually "confounded" or distorted by the presence of fiber. To be a confounder, the factor must be a risk factor for the disease itself. **2. Analysis of Incorrect Options:** * **A. Multifactorial causation:** This refers to the concept that most non-communicable diseases (like cancer) are caused by an interaction of multiple independent risk factors (genetics, diet, lifestyle). While colon cancer is multifactorial, the question specifically asks about the *distortion* of an association by another variable, which defines confounding. * **C. Misclassification:** This is a type of information bias where individuals are placed in the wrong category (e.g., a case labeled as a control). It results from errors in measurement or data collection, not from the presence of an unmeasured third variable. **3. NEET-PG High-Yield Pearls:** * **Criteria for a Confounder:** 1) Associated with exposure, 2) A risk factor for the disease, 3) Not an intermediate step. * **Methods to control confounding:** * *At the Design stage:* Randomization (best method), Matching, and Restriction. * *At the Analysis stage:* Stratification and Multivariate analysis. * **Randomization** is the only method that can control for both known and **unknown** confounders.
Explanation: **Explanation:** The correct answer is **A. H1N1**. In June 2009, the World Health Organization (WHO) declared the **H1N1 "Swine Flu"** strain as the first global influenza pandemic in 41 years. This occurred due to **Antigenic Shift**, a major genetic change resulting in a new subtype to which the general population had little to no immunity. Historically, H1N1 was also responsible for the devastating 1918 "Spanish Flu" pandemic. **Analysis of Incorrect Options:** * **B. H5N1:** Known as **Avian Influenza (Bird Flu)**. While it has a high mortality rate in humans, it has not yet achieved efficient human-to-human transmission required to be declared a pandemic. It remains an epizootic/enzootic threat. * **C. H7N7:** Another strain of Avian Influenza. It has caused outbreaks in poultry and sporadic infections in humans (primarily conjunctivitis), but no sustained community transmission. * **D. H3N3:** This is a subtype found in birds and pigs but is not a significant human pathogen and has never caused a pandemic. (Note: **H3N2** was the cause of the 1968 Hong Kong Flu pandemic). **High-Yield Clinical Pearls for NEET-PG:** * **Antigenic Shift:** Sudden, major change (reassortment) leading to **Pandemics**. * **Antigenic Drift:** Gradual, point mutations leading to **Epidemics** and the need for annual vaccine updates. * **Pandemic Criteria:** A new virus emerges, infects humans, and causes sustained person-to-person transmission across multiple WHO regions. * **Drug of Choice:** Oseltamivir (Tamiflu) is the preferred neuraminidase inhibitor for H1N1.
Explanation: ### Explanation A **Single Exposure Common Vehicle Outbreak** (also known as a Point Source Epidemic) occurs when a group of susceptible individuals is exposed to a common infectious agent or toxin simultaneously or over a very short period. **Why "Explosive" is Correct:** The hallmark of a point source epidemic is its **explosive** nature. Because all individuals are exposed to the same source at roughly the same time, the number of cases rises sharply and clusters within one incubation period. The epidemic curve typically shows a steep upslope and a more gradual downslope (tail), representing a sudden "explosion" of cases. **Analysis of Incorrect Options:** * **A. Frequent secondary cases:** This is characteristic of **Propagated (Person-to-Person) Epidemics** (e.g., Measles). In a single exposure common vehicle outbreak, the disease is usually not transmitted from person to person; cases result only from the common source. * **B. Severity increases with age:** Severity depends on the specific pathogen and host immunity, not the type of exposure. This is not a defining epidemiological characteristic of common vehicle outbreaks. * **C. Cases occur beyond the longest incubation period:** This describes a **Continuous/Multiple Exposure Common Vehicle Outbreak**. In a *single* exposure outbreak, all cases occur within the range of one incubation period. **High-Yield Pearls for NEET-PG:** * **Epidemic Curve:** In a point source epidemic, the curve is **unimodal** (single peak). * **Incubation Period:** You can calculate the median incubation period by identifying the time when 50% of cases have occurred. * **Classic Example:** A food poisoning outbreak at a single wedding feast. * **Key Difference:** If the exposure is brief and simultaneous, it is "Point Source." If the exposure continues over time (e.g., a contaminated well), it is "Continuous Common Source."
Explanation: **Explanation:** The **Breteau Index (BI)** is a key entomological indicator used in the surveillance of **Aedes aegypti**, the primary vector for Dengue, Chikungunya, and Zika virus. It is defined as the **number of positive containers (with larvae or pupae) per 100 houses inspected**. It is considered the most useful index for estimating the density of Aedes mosquitoes in a community because it establishes a relationship between positive containers and houses. **Analysis of Options:** * **Aedes aegypti (Correct):** Along with the Breteau Index, other indices used for Aedes include the **House Index** (percentage of houses positive for larvae) and the **Container Index** (percentage of water-holding containers positive for larvae). * **Anopheles (Incorrect):** Surveillance for Anopheles (Malaria vector) typically involves the **Spleen Index**, **Parasite Index**, or **Annual Parasite Incidence (API)**. Larval density is measured using the "Density per dip" method. * **Culex (Incorrect):** Culex (Filariasis/Japanese Encephalitis vector) is monitored using the **Density Index** (average number of mosquitoes collected per man-hour) or the **Percentage of positive pools**. * **Hookworm (Incorrect):** This is a helminthic infection, not a mosquito. Prevalence is measured via stool examination (eggs per gram). **High-Yield Clinical Pearls for NEET-PG:** * **Aedes aegypti** is known as the "Tiger Mosquito" (due to white stripes) and is a "day biter." * **Critical Threshold:** A Breteau Index **> 20** is generally considered a high risk for the transmission of Dengue fever in a community. * **Aedes** breeds in clean, stagnant water (artificial containers like tires, coolers, and flower pots), whereas **Culex** breeds in dirty, polluted water.
Explanation: **Explanation:** The effectiveness of a screening program depends on the disease having a long **detectable preclinical phase (DPCP)**, high sensitivity/specificity of tests, and evidence that early intervention improves survival. **Why Lung Cancer is the Correct Answer:** Lung cancer is considered the least suitable for mass screening among the options provided. Historically, screening with chest X-rays and sputum cytology failed to reduce mortality. While **Low-Dose CT (LDCT)** is now recommended for high-risk smokers, it has a very high **false-positive rate**, leads to overdiagnosis, and carries risks from invasive follow-up procedures. For the general population, the "lead-time bias" is significant, and the prognosis remains poor even with early detection compared to other cancers. **Analysis of Incorrect Options:** * **Cervix:** The gold standard for screening. It has a long natural history (pre-cancerous stage) and screening via **Pap Smear** or HPV DNA testing has drastically reduced mortality worldwide. * **Breast:** Screening using **Mammography** (and SBE/CBE) is highly effective in detecting early-stage tumors, significantly improving the 5-year survival rate. * **Colorectal:** Screening via **Colonoscopy** or Fecal Occult Blood Test (FOBT) is highly effective because it allows for the identification and removal of precancerous polyps (adenomas). **High-Yield Clinical Pearls for NEET-PG:** * **Wilson and Jungner Criteria:** The classic criteria used to decide if a condition should be screened. * **Iceberg Phenomenon:** Screening is used to detect the "submerged" portion (unmet need/pre-symptomatic cases) of the disease iceberg. * **Lead-time Bias:** The apparent increase in survival time due only to earlier diagnosis, without actually delaying the time of death. * **Length Bias:** Screening tends to detect slowly progressing cases more easily than rapidly fatal ones.
Explanation: **Explanation:** The **Demographic Cycle** describes the historical stages of population growth based on the relationship between birth rates and death rates. **1. Why the Fifth Stage is Correct:** The **Fifth Stage (Declining Stage)** occurs when the **birth rate falls below the death rate**. In this phase, fertility is so low that it cannot replace the existing population, leading to a natural decrease in total numbers. This is currently observed in countries like Germany, Hungary, and Japan. **2. Analysis of Incorrect Options:** * **A. Second Stage (Early Expanding):** Characterized by a high birth rate and a **declining death rate**. This creates a "population explosion" because the gap between births and deaths widens significantly. (e.g., many African countries). * **B. Third Stage (Late Expanding):** The death rate continues to decline further, but the **birth rate also begins to fall**. However, since births still exceed deaths, the population continues to grow. (e.g., India is currently in this stage). * **C. Fourth Stage (Low Stationary):** Characterized by **low birth rates and low death rates**, leading to a stable or stationary population. (e.g., USA, UK). **3. High-Yield Facts for NEET-PG:** * **First Stage (High Stationary):** High birth and high death rates (e.g., India before 1920). * **The "Great Divide":** In India, the year **1921** is known as the "Year of the Big Divide" because the population entered the second stage (mortality began to decline). * **India’s Status:** India is currently in the **Late Expanding (Stage 3)** phase. * **Zero Population Growth:** Occurs in the Fourth Stage when the Net Reproduction Rate (NRR) is 1.
Explanation: According to the latest **GLOBOCAN 2022** data released by the International Agency for Research on Cancer (IARC), **Lung cancer** has re-emerged as the most commonly diagnosed cancer globally. It accounts for approximately 12.4% of all new cases (2.5 million) and remains the leading cause of cancer-related mortality worldwide. ### **Analysis of Options:** * **B. Lung Cancer (Correct):** After briefly being displaced by breast cancer in 2020, lung cancer is once again the #1 most common cancer globally. Its high incidence is driven by tobacco use and increasing air pollution in developing nations. * **A. Breast Cancer:** This is currently the **second** most common cancer worldwide. However, it remains the **most common cancer among females** globally and the most common cancer (overall) in **India**. * **C. Cervical Cancer:** While a significant burden in low-resource settings and the second most common cancer among women in India, it does not rank as the most common globally due to effective screening (Pap smears) and HPV vaccination in developed countries. * **D. Leukemia:** This is the most common malignancy in the **pediatric age group** (children), but it represents a small fraction of the total global cancer burden compared to epithelial tumors. ### **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Cancer (World):** Lung Cancer (2022 data). * **Most Common Cancer (India):** Breast Cancer. * **Leading Cause of Cancer Death (World & India):** Lung Cancer. * **Most Common Cancer in Indian Males:** Lip and Oral Cavity cancer. * **Most Common Cancer in Indian Females:** Breast Cancer (followed by Cervix).
Explanation: ### Explanation **Why the correct answer is right:** The study described is a **Double-blind Randomized Clinical Trial (RCT)**, which is the "Gold Standard" for evaluating the efficacy of a new therapeutic agent. The key features identifying it as such are: 1. **Intervention:** The researchers are actively administering a drug (the independent variable) to a group. 2. **Randomization:** 100 out of 200 patients were chosen "randomly," ensuring that both known and unknown confounders are equally distributed between the groups. 3. **Blinding:** The scenario states that neither the patients (subjects), nor the nurses/doctors (investigators) know who received the drug. This is **Double Blinding**, which eliminates both participant and investigator bias. 4. **Control Group:** The use of orange juice as a placebo provides a baseline for comparison. **Why the incorrect options are wrong:** * **A. Case-control study:** This is a retrospective observational study that starts with the "effect" (disease) and looks back for "cause" (exposure). It does not involve interventions or randomization. * **B. Case report:** This is a descriptive study detailing the clinical features of a single patient. It does not involve a control group or statistical comparison. * **C. Cohort study:** This is an observational study where a group is followed forward in time to see who develops an outcome based on their exposure. Crucially, the researcher does not *assign* the exposure; they merely observe it. **NEET-PG High-Yield Pearls:** * **Randomization** is the "heart" of a clinical trial; it removes **selection bias**. * **Blinding** primarily eliminates **ascertainment/observer bias**. * **Triple Blinding** involves the patient, the investigator, and the data analyst/statistician. * **Phase II Trials** typically focus on efficacy and safety in a small group of patients (like the 200 mentioned here), whereas **Phase III** involves large-scale multicentric trials.
Explanation: **Explanation** The correct answer is **Effectiveness**. In epidemiology, evaluating health interventions requires distinguishing between performance under ideal conditions versus real-world application. 1. **Why Effectiveness is correct:** Effectiveness refers to how well an intervention performs in **"real-world" conditions** or among a **community-dwelling population**. It accounts for variables like patient non-compliance, provider error, and logistical barriers. It answers the question: *"Does it work in practice?"* 2. **Why the other options are incorrect:** * **Efficacy:** This measures the performance of an intervention under **ideal, controlled conditions** (e.g., a Randomized Controlled Trial). It answers: *"Can it work under perfect circumstances?"* * **Efficiency:** This relates to the **cost-benefit ratio**. It measures the results achieved in relation to the resources (money, time, manpower) consumed. It answers: *"Is it worth the cost?"* * **Effect Modification:** This is a methodological concept where the magnitude of the association between an exposure and outcome differs depending on the level of a third variable (the modifier). **High-Yield Clinical Pearls for NEET-PG:** * **Efficacy** = Ideal conditions (RCTs). * **Effectiveness** = Real-world conditions (Community). * **Efficiency** = Resources/Cost-effectiveness. * **Mnemonic:** **E**fficacy is **E**xperimental; **E**ffectiveness is **E**veryday life. * The **"Intent-to-treat"** analysis in trials is often used to estimate effectiveness, as it includes participants regardless of whether they adhered to the protocol.
Principles of Epidemiology
Practice Questions
Measures of Disease Frequency
Practice Questions
Epidemiological Study Designs
Practice Questions
Descriptive Epidemiology
Practice Questions
Analytical Epidemiology
Practice Questions
Experimental Epidemiology
Practice Questions
Screening for Disease
Practice Questions
Surveillance Systems
Practice Questions
Investigation of an Epidemic
Practice Questions
Association and Causation
Practice Questions
Modern Epidemiological Methods
Practice Questions
Critical Appraisal of Epidemiological Studies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free